A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus …
…, J Naude, P Szymanski, Y Vallie… - Clinical Infectious …, 2023 - academic.oup.com
Background Drug regimens that include intensified antibiotics alongside effective anti-inflammatory
therapies may improve outcomes in tuberculous meningitis (TBM). Safety data on …
therapies may improve outcomes in tuberculous meningitis (TBM). Safety data on …
Plasma pharmacokinetics of high-dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial
…, T Crede, J Naude, P Szymanski, Y Vallie… - Antimicrobial agents …, 2021 - Am Soc Microbiol
Higher doses of intravenous rifampicin may improve outcomes in tuberculous meningitis but
are impractical in high-burden settings. We hypothesized that plasma rifampicin exposures …
are impractical in high-burden settings. We hypothesized that plasma rifampicin exposures …
[HTML][HTML] Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated …
…, T Crede, J Naude, P Szymanski, Y Vallie… - Wellcome Open …, 2021 - ncbi.nlm.nih.gov
Background: Tuberculous meningitis (TBM) is the most lethal form of tuberculosis with a
mortality of~ 50% in those co-infected with HIV-1. Current antibiotic regimens are based on …
mortality of~ 50% in those co-infected with HIV-1. Current antibiotic regimens are based on …
[HTML][HTML] Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial
…, P Szymanski, J Naude, S Ebrahim, Y Vallie… - …, 2024 - trialsjournal.biomedcentral.com
HIV-associated tuberculosis (TB) contributes disproportionately to global tuberculosis mortality.
Patients hospitalised at the time of the diagnosis of HIV-associated disseminated TB are …
Patients hospitalised at the time of the diagnosis of HIV-associated disseminated TB are …
The great pretender
S Wasserman, Y Vallie, A Bryer - The Lancet, 2011 - thelancet.com
In November, 2009, a 40-year-old man presented to us because of difficulty in walking, facial
asymmetry, and numbness in both legs. His symptoms had begun 6 weeks earlier with a …
asymmetry, and numbness in both legs. His symptoms had begun 6 weeks earlier with a …
Adam Omar, 31 May 1940-24 March 2021
…, F Kerbelker, S Parker, Y Vallie - SAMJ: South African …, 2021 - scielo.org.za
Adam Omar, son of Aishah Vallie and Mohamed Omar, was born in Observatory, Cape Town,
and educated at the indomitable Trafalgar High School that, in its more than 100 years of …
and educated at the indomitable Trafalgar High School that, in its more than 100 years of …
Retrospective review of glycaemic, lipid and blood pressure control in patients with type 2 diabetes in a major UAE hospital
V Yakoob, A Bachar, EH Ali - 2007 - pesquisa.bvsalud.org
To evaluate to-what extent Tawam Hospital Diabetes Clinic is achieving internationally accepted
targets for gly-caemic control [HbAlc], lipid control, and blood pressure [BP] control. The …
targets for gly-caemic control [HbAlc], lipid control, and blood pressure [BP] control. The …
A randomised controlled trial of N-acetylcysteine in the management of anti-tuberculosis drug-induced liver injury
M Moosa - 2023 - open.uct.ac.za
Background: Liver injury is the most common severe adverse effect of first-line anti-tuberculosis
therapy (ATT). Nacetylcysteine (NAC) has efficacy in patients with paracetamol toxicity, …
therapy (ATT). Nacetylcysteine (NAC) has efficacy in patients with paracetamol toxicity, …
A randomized controlled trial of intravenous N-acetylcysteine in the management of anti-tuberculosis drug–induced liver injury
MS Moosa, G Maartens, H Gunter, S Allie… - Clinical Infectious …, 2021 - academic.oup.com
Background Liver injury is a common complication of anti-tuberculosis therapy. N-acetylcysteine
(NAC) used in patients with paracetamol toxicity with limited evidence of benefit in liver …
(NAC) used in patients with paracetamol toxicity with limited evidence of benefit in liver …
[HTML][HTML] Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol …
T Maitre, M Bonnet, A Calmy, M Raberahona… - Trials, 2022 - Springer
Background Tuberculous meningitis (TBM) is the most lethal and disabling form of tuberculosis
(TB), particularly in sub-Saharan Africa. Current anti-TB treatment is poorly effective since …
(TB), particularly in sub-Saharan Africa. Current anti-TB treatment is poorly effective since …
